The Solana HSV 1+2/VZV assay is a multiplex in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens obtained from symptomatic patients.
The Solana HSV 1+2/VZV assay consists of two major steps: (1) specimen preparation, and (2) amplification and detection of target sequence specific to HSV-1, HSV-2 and/or VZV using isothermal Helicase-Dependent Amplification (HDA) in the presence of target-specific fluorescence probe.
Using HDA technology the target sequences are amplified by HSV-1, HSV-2 and/or VZV specific primers and detected by HSV-1, HSV-2 and/or VZV specific fluorescence probes included in the Reaction Tube. A competitive process control (PRC) is included in the Process Tube to monitor sample processing, inhibitory substances in clinical samples, reagent failure or device failure. The PRC target is amplified by specific primers and detected by a PRC specific fluorescence probe.
Results are displayed on the touchscreen, can be saved to the instrument, printed, and are capable of being sent to the LIS and exported through one of Solana’s five USB ports. Solana HSV 1+2/VZV is also supported by the power of the Virena® system.
Test kit
Catalog number: M302
Control set
Catalog number: M118
The Solana HSV 1+2/VZV assay is a multiplex in vitro diagnostic test for the detection and differentiation of Herpes simplex virus type 1 (HSV-1), Herpes simplex virus type 2 (HSV-2), and Varicella-zoster virus (VZV) nucleic acids isolated and purified from cutaneous or mucocutaneous swab specimens obtained from symptomatic patients.
The Solana HSV 1+2/VZV assay consists of two major steps: (1) specimen preparation, and (2) amplification and detection of target sequence specific to HSV-1, HSV-2 and/or VZV using isothermal Helicase-Dependent Amplification (HDA) in the presence of target-specific fluorescence probe.
Using HDA technology the target sequences are amplified by HSV-1, HSV-2 and/or VZV specific primers and detected by HSV-1, HSV-2 and/or VZV specific fluorescence probes included in the Reaction Tube. A competitive process control (PRC) is included in the Process Tube to monitor sample processing, inhibitory substances in clinical samples, reagent failure or device failure. The PRC target is amplified by specific primers and detected by a PRC specific fluorescence probe.
Results are displayed on the touchscreen, can be saved to the instrument, printed, and are capable of being sent to the LIS and exported through one of Solana’s five USB ports. Solana HSV 1+2/VZV is also supported by the power of the Virena® system.
Test kit
Catalog number: M302
Control set
Catalog number: M118
Features & benefits
Rapid method of isothermal nucleic acid amplification that does not require thermocycling with RT-HDA technology.
Lyophilized Master Mix reagent is an easy-to-use format just add processed sample to rehydrate.
Small instrument eliminates the need for dedicated molecular space and costly capital equipment, allowing for testing in smaller labs.
To access safety data sheets, package inserts, quick reference guides and all other technical and promotional materials, visit our technical documents library.
- Specifications
| Product specifications | |
| Sample type | Cutaneous or mucocutaneous lesion samples obtained from symptomatic patients suspected of active herpes simplex virus type 1, herpes simplex virus type 2 and/or varicella-zoster infection. |
| Time to results | Approxinmately 50 minutes |
| Reagent storage conditions | Process Buffer and Reaction Tubes; 2˚C to 8˚C |
| Controls storage conditions | 2˚C to 8˚C |
| Sensitivity | Cutaneous: HSV-1 100.0%, HSV-2 92.3%, VZV 100%; Mucocutaneous: HSV-1 100%, HSV-2 99.1%, VZV 100.0%; Non categorized HSV-1 100%, HSV-2 100%, VZV 100.0% |
| Specifity | Cutaneous: HSV-1 98.0%, HSV-2 94.4%, VZV 96.5%; Mucocutaneous: HSV-1 96.4%, HSV-2 97.2%, VZV 98.6%; Non categorized HSV-1 97.9%, HSV-2 96.6%, VZV 94.1 |
Related products
- View all
- By disease and condition
